Showing results (11-20 of 38) with videos related to
Sort By:
Pageof 4
Plos One|February 15, 2022
FGFR2 overexpression and compromised survival in diffuse-type gastric cancer in a large central European cohortThorben Schrumpf, Hans-Michael Behrens, Jochen Haag, et al.Methods in Molecular Medicine|July 29, 2004
Quantification of mRNA expression levels in articular chondrocytes with PCR technologiesAudrey McAlinden, Jochen Haag, Brigitte Bau, et al.Virchows Archiv : an International Journal of Pathology|October 11, 2023
MDM2 amplification is rare in gastric cancerSamir Abdullazade, Hans-Michael Behrens, Sandra Krüger, et al.Frontiers in Bioscience : a Journal and Virtual Library|June 23, 2005
The human chondrosarcoma HCS-2/8 cell line is responsive to BMP-7, but not to IL-1betaJoachim Saas, Matthias Gebauer, Carsten Jacobi, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 10, 2002
Bone morphogenetic protein-mediating receptor-associated Smads as well as common Smad are expressed in human articular chondrocytes but not up-regulated or down-regulated in osteoarthritic cartilageBrigitte Bau, Jochen Haag, Erik Schmid, et al.Arthritis and Rheumatism|October 18, 2002
Relative messenger RNA expression profiling of collagenases and aggrecanases in human articular chondrocytes in vivo and in vitroBrigitte Bau, Pia M Gebhard, Jochen Haag, et al.The Journal of Pathology|November 7, 2023
CD27/CD70 pathway activation in primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorderJulia Richter, Ilske Oschlies, Katharina Kock, et al.Arthritis Research & Therapy|March 4, 2005
Repression of anti-proliferative factor Tob1 in osteoarthritic cartilageMathias Gebauer, Joachim Saas, Jochen Haag, et al.Human Pathology|September 24, 2020
p53 immunostaining cannot be used to predict TP53 mutations in gastric cancer: results from a large Central European cohortIsabelle Schoop, Saffiyeh Saboor Maleki, Hans-Michael Behrens, et al.Histopathology|June 3, 2015
MET in gastric cancer--discarding a 10% cutoff ruleMarie-Luise Metzger, Hans-Michael Behrens, Christine Böger, et al.Pageof 4